JP2024538792A - 無血清浮遊培養に適したhek293細胞株及びその応用 - Google Patents
無血清浮遊培養に適したhek293細胞株及びその応用 Download PDFInfo
- Publication number
- JP2024538792A JP2024538792A JP2024522383A JP2024522383A JP2024538792A JP 2024538792 A JP2024538792 A JP 2024538792A JP 2024522383 A JP2024522383 A JP 2024522383A JP 2024522383 A JP2024522383 A JP 2024522383A JP 2024538792 A JP2024538792 A JP 2024538792A
- Authority
- JP
- Japan
- Prior art keywords
- cells
- medium
- cell
- serum
- culture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0684—Cells of the urinary tract or kidneys
- C12N5/0686—Kidney cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14151—Methods of production or purification of viral material
- C12N2750/14152—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Virology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111190063.4 | 2021-10-12 | ||
| CN202111190063 | 2021-10-12 | ||
| PCT/CN2022/124873 WO2023061409A1 (zh) | 2021-10-12 | 2022-10-12 | 适应无血清悬浮培养的hek293细胞株及其应用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024538792A true JP2024538792A (ja) | 2024-10-23 |
| JP2024538792A5 JP2024538792A5 (https=) | 2025-12-05 |
| JPWO2023061409A5 JPWO2023061409A5 (https=) | 2025-12-05 |
Family
ID=85987273
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024522383A Pending JP2024538792A (ja) | 2021-10-12 | 2022-10-12 | 無血清浮遊培養に適したhek293細胞株及びその応用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240425880A1 (https=) |
| EP (1) | EP4417689A4 (https=) |
| JP (1) | JP2024538792A (https=) |
| KR (1) | KR20240070587A (https=) |
| CN (1) | CN118660958A (https=) |
| WO (1) | WO2023061409A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN121586778A (zh) * | 2023-04-26 | 2026-02-27 | 赛诺菲 | 宿主细胞系以及用于鉴定和使用此类宿主细胞系的方法 |
| CN117089514A (zh) * | 2023-10-13 | 2023-11-21 | 思鹏生物科技(苏州)有限公司 | 提升hek293细胞系aav生产效率的细胞筛选驯化方法 |
| CN117402817B (zh) * | 2023-10-31 | 2024-09-27 | 山东丽山生物科技有限公司 | 一种无血清培养驯化贴壁293t细胞的方法及其应用 |
| WO2025171001A1 (en) | 2024-02-06 | 2025-08-14 | Regeneron Pharmaceuticals, Inc. | Compositions and methods for improved production of aav viral vectors |
| CN118222630B (zh) * | 2024-05-23 | 2024-08-27 | 江西赛基生物技术有限公司 | 一种稳转表达cd16跨膜蛋白细胞系的构建方法及应用 |
| CN119639654B (zh) * | 2024-12-24 | 2025-10-31 | 华元(上海)生物医药有限公司 | 一种人胚胎肾单克隆细胞株及其在生产慢病毒载体中的应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT2782997T (pt) * | 2011-11-24 | 2018-04-09 | Genethon | Sistema de produção de vetor lentiviral escalável compatível com aplicações farmacêuticas industriais |
| CN102604889B (zh) * | 2012-03-19 | 2013-05-08 | 中国农业科学院哈尔滨兽医研究所 | 适应无血清培养的hek293细胞系及其应用 |
| RU2709678C2 (ru) * | 2013-03-15 | 2019-12-19 | Дзе Чилдрен'З Хоспитал Оф Филадельфия | Масштабный производственный способ получения рекомбинантных лентивирусных векторов в системе культивирования клеток в бессывороточной суспензии |
| CN104450607B (zh) * | 2014-11-14 | 2017-07-11 | 武汉金开瑞生物工程有限公司 | 用于hek293细胞悬浮生长的全化学成分培养基及培养方法 |
| CN110713971B (zh) * | 2019-11-06 | 2021-08-27 | 深圳市菲鹏生物治疗股份有限公司 | 一种无血清悬浮培养型293t细胞、其制备方法以及病毒的包装方法 |
| KR20230126214A (ko) * | 2020-12-29 | 2023-08-29 | 지앙수 젠스크립트 프로바이오 바이오테크 컴퍼니 리미티드 | 고분산성 hek293t 세포주 및 이의 스크리닝 방법 |
-
2022
- 2022-10-12 JP JP2024522383A patent/JP2024538792A/ja active Pending
- 2022-10-12 KR KR1020247012818A patent/KR20240070587A/ko active Pending
- 2022-10-12 WO PCT/CN2022/124873 patent/WO2023061409A1/zh not_active Ceased
- 2022-10-12 EP EP22880345.8A patent/EP4417689A4/en active Pending
- 2022-10-12 CN CN202280068776.XA patent/CN118660958A/zh active Pending
- 2022-10-12 US US18/700,983 patent/US20240425880A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN118660958A (zh) | 2024-09-17 |
| US20240425880A1 (en) | 2024-12-26 |
| EP4417689A4 (en) | 2025-10-15 |
| KR20240070587A (ko) | 2024-05-21 |
| WO2023061409A1 (zh) | 2023-04-20 |
| EP4417689A1 (en) | 2024-08-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7561788B2 (ja) | 臨床使用に適した無血清懸濁細胞培養システムにおいて組換えアデノ随伴ウイルス(aav)ベクターを産生するスケーラブルな方法 | |
| EP4417689A1 (en) | Hek293 cell line adapted to serum-free suspension culture and use thereof | |
| JP7801093B2 (ja) | 細胞トランスフェクション及び/又はrAAVベクター産生の改善のための増強剤 | |
| CN104520421B (zh) | 用于生产腺伴随病毒的细胞系 | |
| JP7846625B2 (ja) | 組換えaavの産生 | |
| WO2011097447A2 (en) | Production of recombinant virus | |
| US20240279682A1 (en) | AAV Manufacturing Methods | |
| WO2024143440A1 (ja) | アデノ随伴ウイルスの製造方法、およびベクターのセット | |
| HK40117756A (zh) | 用於生产重组aav颗粒的方法 | |
| WO2026020116A1 (en) | Methods and compositions for enriching the production of dna cargo loaded recombinant adeno-associated virus capsids | |
| WO2025047766A1 (ja) | ウイルスの製造方法および細胞への核酸導入方法 | |
| WO2025168663A1 (en) | Method for producing recombinant adeno-associated viral particles | |
| JP2026511015A (ja) | 組換えaav粒子調製物の生成のための方法 | |
| TW202405182A (zh) | 生產重組aav顆粒之方法 | |
| HK40117143A (zh) | 用於生产重组aav颗粒的方法 | |
| HK40081423A (en) | Recombinant aav production |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20251010 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20251010 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20251126 |